Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 34 entries
Sorted by: Best Match Show Resources per page
Synchronous uterine adenocarcinoma and leiomyosarcoma - a case study.

Przeglad menopauzalny = Menopause review

Dudzik K, Krzysteczko A, Kolny L, Bąk A, Stawicka-Ociepka E, Nowosielski K.
PMID: 28546804
Prz Menopauzalny. 2017 Mar;16(1):23-25. doi: 10.5114/pm.2017.67367. Epub 2017 Apr 26.

Synchronous gynecological cancers are rarely described. Those cases account for approximately up to 6% of female genital tract malignancies. The presence of synchronous endometrial adenocarcinoma and gynecological tract neoplasia is rare - the most commonly described is synchronous adenocarcinoma...

Cite
Dudzik K, Krzysteczko A, Kolny L, et al. Synchronous uterine adenocarcinoma and leiomyosarcoma - a case study. Prz Menopauzalny. 2017;16(1):23-25doi: 10.5114/pm.2017.67367.
Dudzik, K., Krzysteczko, A., Kolny, L., Bąk, A., Stawicka-Ociepka, E., & Nowosielski, K. (2017). Synchronous uterine adenocarcinoma and leiomyosarcoma - a case study. Przeglad menopauzalny = Menopause review, 16(1), 23-25. https://doi.org/10.5114/pm.2017.67367
Dudzik, Kamila, et al. "Synchronous uterine adenocarcinoma and leiomyosarcoma - a case study." Przeglad menopauzalny = Menopause review vol. 16,1 (2017): 23-25. doi: https://doi.org/10.5114/pm.2017.67367
Dudzik K, Krzysteczko A, Kolny L, Bąk A, Stawicka-Ociepka E, Nowosielski K. Synchronous uterine adenocarcinoma and leiomyosarcoma - a case study. Prz Menopauzalny. 2017 Mar;16(1):23-25. doi: 10.5114/pm.2017.67367. Epub 2017 Apr 26. PMID: 28546804; PMCID: PMC5437056.
Copy Download .nbib Format: NLM
Macular Hole Surgery in the Case of Wet Age-Related Macular Degeneration Treated with Intravitreal Aflibercept.

Case reports in ophthalmology

Nowosielska A.
PMID: 31762770
Case Rep Ophthalmol. 2019 Oct 24;10(3):369-373. doi: 10.1159/000503415. eCollection 2019.

A 72-year-old male treated with aflibercept (Eylea) due to choroidal neovascularization (CNV) in his left eye developed a full-thickness macular hole (MH) after the second injection. The occurrence of MH in his left eye resulted in further visual acuity...

Cite
Nowosielska A. Macular Hole Surgery in the Case of Wet Age-Related Macular Degeneration Treated with Intravitreal Aflibercept. Case Rep Ophthalmol. 2019;10(3):369-373doi: 10.1159/000503415.
Nowosielska, A. (2019). Macular Hole Surgery in the Case of Wet Age-Related Macular Degeneration Treated with Intravitreal Aflibercept. Case reports in ophthalmology, 10(3), 369-373. https://doi.org/10.1159/000503415
Nowosielska, Agnieszka. "Macular Hole Surgery in the Case of Wet Age-Related Macular Degeneration Treated with Intravitreal Aflibercept." Case reports in ophthalmology vol. 10,3 (2019): 369-373. doi: https://doi.org/10.1159/000503415
Nowosielska A. Macular Hole Surgery in the Case of Wet Age-Related Macular Degeneration Treated with Intravitreal Aflibercept. Case Rep Ophthalmol. 2019 Oct 24;10(3):369-373. doi: 10.1159/000503415. eCollection 2019. PMID: 31762770; PMCID: PMC6873050.
Copy Download .nbib Format: NLM
Mechanical and Corrosion Properties of Mg-Based Alloys with Gd Addition.

Materials (Basel, Switzerland)

Kania A, Nowosielski R, Gawlas-Mucha A, Babilas R.
PMID: 31159193
Materials (Basel). 2019 May 31;12(11). doi: 10.3390/ma12111775.

Magnesium alloys with rare earth metals are very attractive materials for medical application because of satisfactory mechanical properties. Nevertheless, low corrosion resistance is an obstacle in the use of Mg alloys as resorbable orthopedic implants. The paper presents results...

Cite
Kania A, Nowosielski R, Gawlas-Mucha A, et al. Mechanical and Corrosion Properties of Mg-Based Alloys with Gd Addition. Materials (Basel). 2019;12(11)doi: 10.3390/ma12111775.
Kania, A., Nowosielski, R., Gawlas-Mucha, A., & Babilas, R. (2019). Mechanical and Corrosion Properties of Mg-Based Alloys with Gd Addition. Materials (Basel, Switzerland), 12(11), . https://doi.org/10.3390/ma12111775
Kania, Aneta, et al. "Mechanical and Corrosion Properties of Mg-Based Alloys with Gd Addition." Materials (Basel, Switzerland) vol. 12,11 (2019). doi: https://doi.org/10.3390/ma12111775
Kania A, Nowosielski R, Gawlas-Mucha A, Babilas R. Mechanical and Corrosion Properties of Mg-Based Alloys with Gd Addition. Materials (Basel). 2019 May 31;12(11). doi: 10.3390/ma12111775. PMID: 31159193; PMCID: PMC6600794.
Copy Download .nbib Format: NLM
Recombinant activated factor VII administration in a patient with congenital lack of factor VII undergoing laparoscopic hysterectomy: A case report.

International journal of surgery case reports

Dąbrowski FA, Sadlik N, Nowosielski K.
PMID: 33418422
Int J Surg Case Rep. 2021 Feb;79:11-13. doi: 10.1016/j.ijscr.2020.12.093. Epub 2021 Jan 02.

INTRODUCTION AND IMPORTANCE: Case report of patient with congenital lack of factor VII, suffering from recurrent hematomas and massive menstrual bleedings resulting in severe anemia and multiple hospitalization.CASE PRESENTATION: Patient was diagnosed with endometrial hyperplasia and not responding to...

Cite
Dąbrowski FA, Sadlik N, Nowosielski K. Recombinant activated factor VII administration in a patient with congenital lack of factor VII undergoing laparoscopic hysterectomy: A case report. Int J Surg Case Rep. 2021;79:11-13doi: 10.1016/j.ijscr.2020.12.093.
Dąbrowski, F. A., Sadlik, N., & Nowosielski, K. (2021). Recombinant activated factor VII administration in a patient with congenital lack of factor VII undergoing laparoscopic hysterectomy: A case report. International journal of surgery case reports, 7911-13. https://doi.org/10.1016/j.ijscr.2020.12.093
Dąbrowski, Filip A, et al. "Recombinant activated factor VII administration in a patient with congenital lack of factor VII undergoing laparoscopic hysterectomy: A case report." International journal of surgery case reports vol. 79 (2021): 11-13. doi: https://doi.org/10.1016/j.ijscr.2020.12.093
Dąbrowski FA, Sadlik N, Nowosielski K. Recombinant activated factor VII administration in a patient with congenital lack of factor VII undergoing laparoscopic hysterectomy: A case report. Int J Surg Case Rep. 2021 Feb;79:11-13. doi: 10.1016/j.ijscr.2020.12.093. Epub 2021 Jan 02. PMID: 33418422; PMCID: PMC7804344.
Copy Download .nbib Format: NLM
Effects of Intravitreal Aflibercept on the Systemic Insulin-like Growth Factor-I and Vascular Endothelial Growth Factor-A in Patients with Diabetic Retinopathy and Age-Related Macular Degeneration.

Journal of ophthalmology

Huber AL, Angermann R, Nowosielski Y, Seifarth C, Kralinger MT, Zehetner C.
PMID: 34956670
J Ophthalmol. 2021 Dec 15;2021:7058505. doi: 10.1155/2021/7058505. eCollection 2021.

PURPOSE: To analyze the effect of intravitreal aflibercept injections on systemic levels of insulin-like growth factor-1 and vascular endothelial growth factor-A in patients with diabetic retinopathy and age-related macular degeneration.METHODS: Vascular endothelial growth factor-A and insulin-like growth factor-1 levels...

Cite
Huber AL, Angermann R, Nowosielski Y, et al. Effects of Intravitreal Aflibercept on the Systemic Insulin-like Growth Factor-I and Vascular Endothelial Growth Factor-A in Patients with Diabetic Retinopathy and Age-Related Macular Degeneration. J Ophthalmol. 2021;2021:7058505doi: 10.1155/2021/7058505.
Huber, A. L., Angermann, R., Nowosielski, Y., Seifarth, C., Kralinger, M. T., & Zehetner, C. (2021). Effects of Intravitreal Aflibercept on the Systemic Insulin-like Growth Factor-I and Vascular Endothelial Growth Factor-A in Patients with Diabetic Retinopathy and Age-Related Macular Degeneration. Journal of ophthalmology, 20217058505. https://doi.org/10.1155/2021/7058505
Huber, Anna Lena, et al. "Effects of Intravitreal Aflibercept on the Systemic Insulin-like Growth Factor-I and Vascular Endothelial Growth Factor-A in Patients with Diabetic Retinopathy and Age-Related Macular Degeneration." Journal of ophthalmology vol. 2021 (2021): 7058505. doi: https://doi.org/10.1155/2021/7058505
Huber AL, Angermann R, Nowosielski Y, Seifarth C, Kralinger MT, Zehetner C. Effects of Intravitreal Aflibercept on the Systemic Insulin-like Growth Factor-I and Vascular Endothelial Growth Factor-A in Patients with Diabetic Retinopathy and Age-Related Macular Degeneration. J Ophthalmol. 2021 Dec 15;2021:7058505. doi: 10.1155/2021/7058505. eCollection 2021. PMID: 34956670; PMCID: PMC8694974.
Copy Download .nbib Format: NLM
Levels of Selected Matrix Metalloproteinases-MMP-1, MMP-2 and Fibronectin in the Saliva of Patients Planned for Endodontic Treatment or Surgical Extraction.

Journal of clinical medicine

Matuszczak E, Cwalina I, Tylicka M, Wawrzyn K, Nowosielska M, Sankiewicz A, Ołdak Ł, Gorodkiewicz E, Hermanowicz A.
PMID: 33297580
J Clin Med. 2020 Dec 07;9(12). doi: 10.3390/jcm9123971.

OBJECTIVES: Composition of saliva reflects the condition of the oral cavity.THE AIM OF THE STUDY: Investigation of the concentrations of MMP-1 (Matrix metalloproteinase-1), MMP-2 (Matrix metalloproteinase-2) and fibronectin in the saliva of patients planned for endodontic treatment or surgical...

Cite
Matuszczak E, Cwalina I, Tylicka M, et al. Levels of Selected Matrix Metalloproteinases-MMP-1, MMP-2 and Fibronectin in the Saliva of Patients Planned for Endodontic Treatment or Surgical Extraction. J Clin Med. 2020;9(12)doi: 10.3390/jcm9123971.
Matuszczak, E., Cwalina, I., Tylicka, M., Wawrzyn, K., Nowosielska, M., Sankiewicz, A., Ołdak, �. �., Gorodkiewicz, E., & Hermanowicz, A. (2020). Levels of Selected Matrix Metalloproteinases-MMP-1, MMP-2 and Fibronectin in the Saliva of Patients Planned for Endodontic Treatment or Surgical Extraction. Journal of clinical medicine, 9(12), . https://doi.org/10.3390/jcm9123971
Matuszczak, Ewa, et al. "Levels of Selected Matrix Metalloproteinases-MMP-1, MMP-2 and Fibronectin in the Saliva of Patients Planned for Endodontic Treatment or Surgical Extraction." Journal of clinical medicine vol. 9,12 (2020). doi: https://doi.org/10.3390/jcm9123971
Matuszczak E, Cwalina I, Tylicka M, Wawrzyn K, Nowosielska M, Sankiewicz A, Ołdak Ł, Gorodkiewicz E, Hermanowicz A. Levels of Selected Matrix Metalloproteinases-MMP-1, MMP-2 and Fibronectin in the Saliva of Patients Planned for Endodontic Treatment or Surgical Extraction. J Clin Med. 2020 Dec 07;9(12). doi: 10.3390/jcm9123971. PMID: 33297580; PMCID: PMC7762352.
Copy Download .nbib Format: NLM
Systemic counterregulatory response of angiopoietin-2 after aflibercept therapy for nAMD: a potential escape mechanism.

Acta ophthalmologica

Angermann R, Rauchegger T, Nowosielski Y, Seifarth C, Egger S, Kralinger MT, Kieselbach GF, Zehetner C.
PMID: 33326179
Acta Ophthalmol. 2021 Sep;99(6):e869-e875. doi: 10.1111/aos.14691. Epub 2020 Dec 16.

PURPOSE: To analyse the effect of intravitreal aflibercept injections on systemic angiopoietin-2 (Ang2) and vascular endothelial growth factor (VEGF)-A levels in patients with neovascular age-related macular degeneration (nAMD).METHODS: In a prospective, randomized study, aflibercept (2.0 mg/50 µl) or ranibizumab...

Cite
Angermann R, Rauchegger T, Nowosielski Y, et al. Systemic counterregulatory response of angiopoietin-2 after aflibercept therapy for nAMD: a potential escape mechanism. Acta Ophthalmol. 2020;99(6):e869-e875doi: 10.1111/aos.14691.
Angermann, R., Rauchegger, T., Nowosielski, Y., Seifarth, C., Egger, S., Kralinger, M. T., Kieselbach, G. F., & Zehetner, C. (2021). Systemic counterregulatory response of angiopoietin-2 after aflibercept therapy for nAMD: a potential escape mechanism. Acta ophthalmologica, 99(6), e869-e875. https://doi.org/10.1111/aos.14691
Angermann, Reinhard, et al. "Systemic counterregulatory response of angiopoietin-2 after aflibercept therapy for nAMD: a potential escape mechanism." Acta ophthalmologica vol. 99,6 (2021): e869-e875. doi: https://doi.org/10.1111/aos.14691
Angermann R, Rauchegger T, Nowosielski Y, Seifarth C, Egger S, Kralinger MT, Kieselbach GF, Zehetner C. Systemic counterregulatory response of angiopoietin-2 after aflibercept therapy for nAMD: a potential escape mechanism. Acta Ophthalmol. 2021 Sep;99(6):e869-e875. doi: 10.1111/aos.14691. Epub 2020 Dec 16. PMID: 33326179; PMCID: PMC8519089.
Copy Download .nbib Format: NLM
Changes in Brain Energy and Membrane Metabolism in Glioblastoma following Chemoradiation.

Current oncology (Toronto, Ont.)

Grams AE, Mangesius S, Steiger R, Radovic I, Rietzler A, Walchhofer LM, Galijašević M, Mangesius J, Nowosielski M, Freyschlag CF, Kerschbaumer J, Gizewski ER.
PMID: 34940063
Curr Oncol. 2021 Dec 01;28(6):5041-5053. doi: 10.3390/curroncol28060424.

Brain parenchyma infiltration with glioblastoma (GB) cannot be entirely visualized by conventional magnetic resonance imaging (MRI). The aim of this study was to investigate changes in the energy and membrane metabolism measured with phosphorous MR spectroscopy (31P-MRS) in the...

Cite
Grams AE, Mangesius S, Steiger R, et al. Changes in Brain Energy and Membrane Metabolism in Glioblastoma following Chemoradiation. Curr Oncol. 2021;28(6):5041-5053doi: 10.3390/curroncol28060424.
Grams, A. E., Mangesius, S., Steiger, R., Radovic, I., Rietzler, A., Walchhofer, L. M., Galijašević, M., Mangesius, J., Nowosielski, M., Freyschlag, C. F., Kerschbaumer, J., & Gizewski, E. R. (2021). Changes in Brain Energy and Membrane Metabolism in Glioblastoma following Chemoradiation. Current oncology (Toronto, Ont.), 28(6), 5041-5053. https://doi.org/10.3390/curroncol28060424
Grams, Astrid Ellen, et al. "Changes in Brain Energy and Membrane Metabolism in Glioblastoma following Chemoradiation." Current oncology (Toronto, Ont.) vol. 28,6 (2021): 5041-5053. doi: https://doi.org/10.3390/curroncol28060424
Grams AE, Mangesius S, Steiger R, Radovic I, Rietzler A, Walchhofer LM, Galijašević M, Mangesius J, Nowosielski M, Freyschlag CF, Kerschbaumer J, Gizewski ER. Changes in Brain Energy and Membrane Metabolism in Glioblastoma following Chemoradiation. Curr Oncol. 2021 Dec 01;28(6):5041-5053. doi: 10.3390/curroncol28060424. PMID: 34940063.
Copy Download .nbib Format: NLM
Proton beam radiation for iris melanoma: case series and review of literature.

BMJ open ophthalmology

Hauzinger JA, Blatsios G, Haas G, Zehetner C, Velez-Escola L, Nowosielski Y, Seifarth C, Rauchegger T, Haider B, Bechrakis NE.
PMID: 35018306
BMJ Open Ophthalmol. 2021 Dec 23;6(1):e000683. doi: 10.1136/bmjophth-2020-000683. eCollection 2021.

OBJECTIVE: Purpose of this study is to analyse the visual outcomes, the complication and eye retention rate as well as tumour control data of patients treated with proton beam radiation therapy (PBRT) for iris melanoma.METHODS: Retrospective case series and...

Cite
Hauzinger JA, Blatsios G, Haas G, et al. Proton beam radiation for iris melanoma: case series and review of literature. BMJ Open Ophthalmol. 2021;6(1):e000683doi: 10.1136/bmjophth-2020-000683.
Hauzinger, J. A., Blatsios, G., Haas, G., Zehetner, C., Velez-Escola, L., Nowosielski, Y., Seifarth, C., Rauchegger, T., Haider, B., & Bechrakis, N. E. (2021). Proton beam radiation for iris melanoma: case series and review of literature. BMJ open ophthalmology, 6(1), e000683. https://doi.org/10.1136/bmjophth-2020-000683
Hauzinger, Jasmine Alexandra, et al. "Proton beam radiation for iris melanoma: case series and review of literature." BMJ open ophthalmology vol. 6,1 (2021): e000683. doi: https://doi.org/10.1136/bmjophth-2020-000683
Hauzinger JA, Blatsios G, Haas G, Zehetner C, Velez-Escola L, Nowosielski Y, Seifarth C, Rauchegger T, Haider B, Bechrakis NE. Proton beam radiation for iris melanoma: case series and review of literature. BMJ Open Ophthalmol. 2021 Dec 23;6(1):e000683. doi: 10.1136/bmjophth-2020-000683. eCollection 2021. PMID: 35018306; PMCID: PMC8705205.
Copy Download .nbib Format: NLM
Body image during sexual activity in the population of Polish adult women.

Przeglad menopauzalny = Menopause review

Nowosielski K, Kurpisz J, Kowalczyk R.
PMID: 32132883
Prz Menopauzalny. 2019 Dec;18(4):198-209. doi: 10.5114/pm.2019.93118. Epub 2020 Jan 15.

INTRODUCTION: Recently it has been shown that body image during sexual activities is a better predictor of the diversity of sexual experience than body image as a psychological trait. To measure contextual body image (as a state) the Body...

Cite
Nowosielski K, Kurpisz J, Kowalczyk R. Body image during sexual activity in the population of Polish adult women. Prz Menopauzalny. 2020;18(4):198-209doi: 10.5114/pm.2019.93118.
Nowosielski, K., Kurpisz, J., & Kowalczyk, R. (2019). Body image during sexual activity in the population of Polish adult women. Przeglad menopauzalny = Menopause review, 18(4), 198-209. https://doi.org/10.5114/pm.2019.93118
Nowosielski, Krzysztof, et al. "Body image during sexual activity in the population of Polish adult women." Przeglad menopauzalny = Menopause review vol. 18,4 (2019): 198-209. doi: https://doi.org/10.5114/pm.2019.93118
Nowosielski K, Kurpisz J, Kowalczyk R. Body image during sexual activity in the population of Polish adult women. Prz Menopauzalny. 2019 Dec;18(4):198-209. doi: 10.5114/pm.2019.93118. Epub 2020 Jan 15. PMID: 32132883; PMCID: PMC7045354.
Copy Download .nbib Format: NLM
Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized Trial.

Cancers

Buchroithner J, Erhart F, Pichler J, Widhalm G, Preusser M, Stockhammer G, Nowosielski M, Iglseder S, Freyschlag CF, Oberndorfer S, Bordihn K, von Campe G, Hoffermann M, Ruckser R, Rössler K, Spiegl-Kreinecker S, Fischer MB, Czech T, Visus C, Krumpl G, Felzmann T, Marosi C.
PMID: 30301187
Cancers (Basel). 2018 Oct 05;10(10). doi: 10.3390/cancers10100372.

Dendritic cells (DCs) are antigen-presenting cells that are capable of priming anti-tumor immune responses, thus serving as attractive tools to generate tumor vaccines. In this multicentric randomized open-label phase II study, we investigated the efficacy of vaccination with tumor...

Cite
Buchroithner J, Erhart F, Pichler J, et al. Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized Trial. Cancers (Basel). 2018;10(10)doi: 10.3390/cancers10100372.
Buchroithner, J., Erhart, F., Pichler, J., Widhalm, G., Preusser, M., Stockhammer, G., Nowosielski, M., Iglseder, S., Freyschlag, C. F., Oberndorfer, S., Bordihn, K., von Campe, G., Hoffermann, M., Ruckser, R., Rössler, K., Spiegl-Kreinecker, S., Fischer, M. B., Czech, T., Visus, C., Krumpl, G., Felzmann, T., & Marosi, C. (2018). Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized Trial. Cancers, 10(10), . https://doi.org/10.3390/cancers10100372
Buchroithner, Johanna, et al. "Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized Trial." Cancers vol. 10,10 (2018). doi: https://doi.org/10.3390/cancers10100372
Buchroithner J, Erhart F, Pichler J, Widhalm G, Preusser M, Stockhammer G, Nowosielski M, Iglseder S, Freyschlag CF, Oberndorfer S, Bordihn K, von Campe G, Hoffermann M, Ruckser R, Rössler K, Spiegl-Kreinecker S, Fischer MB, Czech T, Visus C, Krumpl G, Felzmann T, Marosi C. Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized Trial. Cancers (Basel). 2018 Oct 05;10(10). doi: 10.3390/cancers10100372. PMID: 30301187; PMCID: PMC6210090.
Copy Download .nbib Format: NLM
How fast does wasp venom immunotherapy affect a regulatory T cell subpopulation (CD4+ CD25+ Foxp3+) and the synthesis of interleukins 10, 21 and transforming growth factor β1?.

Postepy dermatologii i alergologii

Zakrzewski A, Kruszewski J, Chciałowski A, Kłos K, Rzeszotarska A, Korsak J, Nowosielska EM, Cheda A, Wrembel-Wargocka J, Janiak MK.
PMID: 30858784
Postepy Dermatol Alergol. 2019 Feb;36(1):82-85. doi: 10.5114/ada.2019.82828. Epub 2019 Feb 22.

INTRODUCTION: The literature describes the influence of venom immunotherapy (VIT) on the subpopulation of T regulatory cells (CD4+ CD25+ Foxp3+) and the synthesis of IL-10, TGF-β1 as well as many other cytokines at various times after immunotherapy.AIM: To assess...

Cite
Zakrzewski A, Kruszewski J, Chciałowski A, et al. How fast does wasp venom immunotherapy affect a regulatory T cell subpopulation (CD4+ CD25+ Foxp3+) and the synthesis of interleukins 10, 21 and transforming growth factor β1?. Postepy Dermatol Alergol. 2019;36(1):82-85doi: 10.5114/ada.2019.82828.
Zakrzewski, A., Kruszewski, J., Chciałowski, A., Kłos, K., Rzeszotarska, A., Korsak, J., Nowosielska, E. M., Cheda, A., Wrembel-Wargocka, J., & Janiak, M. K. (2019). How fast does wasp venom immunotherapy affect a regulatory T cell subpopulation (CD4+ CD25+ Foxp3+) and the synthesis of interleukins 10, 21 and transforming growth factor β1?. Postepy dermatologii i alergologii, 36(1), 82-85. https://doi.org/10.5114/ada.2019.82828
Zakrzewski, Aleksander, et al. "How fast does wasp venom immunotherapy affect a regulatory T cell subpopulation (CD4+ CD25+ Foxp3+) and the synthesis of interleukins 10, 21 and transforming growth factor β1?." Postepy dermatologii i alergologii vol. 36,1 (2019): 82-85. doi: https://doi.org/10.5114/ada.2019.82828
Zakrzewski A, Kruszewski J, Chciałowski A, Kłos K, Rzeszotarska A, Korsak J, Nowosielska EM, Cheda A, Wrembel-Wargocka J, Janiak MK. How fast does wasp venom immunotherapy affect a regulatory T cell subpopulation (CD4+ CD25+ Foxp3+) and the synthesis of interleukins 10, 21 and transforming growth factor β1?. Postepy Dermatol Alergol. 2019 Feb;36(1):82-85. doi: 10.5114/ada.2019.82828. Epub 2019 Feb 22. PMID: 30858784; PMCID: PMC6409867.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 34 entries